RENSANSE
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Aug 2024)
What this means for you
This application is over — abandoned 26 Aug 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97761623
- Mark type
- Stylized text
- Filed
- 19 Jan 2023
- Published for opposition
- 28 Nov 2023
- Abandoned
- 26 Aug 2024
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, prescription psychotropic drugs; Psychotherapeutic preparations for managing and treating mental illnesses and psychiatric, psychological, and neurological disorders and conditions affecting mood, thought, behavior, and perception; Pharmaceutical preparations for the treatment and management of psychiatric, psychological, and neurological disorders; Therapeutic agents for treating and managing PTSD, eating disorders, postpartum depression, alcohol use disorder, opioid and substance use disorder, generalized anxiety disorder, social anxiety disorder, major depressive disorder, and traumatic brain injury; Medicaments to help assist with treatment and management of psychiatric, psychological, and neurological disorders
Owner
- LYKOS THERAPEUTICS, INC., BOSTON, MA, US
- MAPS Public Benefit Corporation, Boston, MA, US
- MAPS Public Benefit Corporation, Boston, MA, US
Prosecution history
- 26 Aug 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Aug 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 Jan 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Nov 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Nov 2023 — PUBLISHED FOR OPPOSITION
- 08 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Oct 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Oct 2023 — EXAMINER'S AMENDMENT ENTERED
- 25 Oct 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Oct 2023 — EXAMINERS AMENDMENT E-MAILED
- 25 Oct 2023 — EXAMINERS AMENDMENT -WRITTEN
- 24 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2023 — NON-FINAL ACTION E-MAILED
- 24 Oct 2023 — NON-FINAL ACTION WRITTEN